- €70.87bn
- €134.41bn
- €49.34bn
- 71
- 50
- 93
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 36,438 | 33,145 | 39,114 | 53,949 | 49,335 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30,507 | 27,105 | 31,771 | 45,965 | 40,362 |
Operating Profit | 5,931 | 6,040 | 7,343 | 7,984 | 8,973 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,794 | 5,053 | 6,301 | 6,292 | 7,025 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,880 | 3,970 | 4,387 | 5,131 | 5,415 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,406 | 3,611 | 3,885 | 4,339 | 4,803 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,406 | 3,611 | 3,885 | 4,339 | 4,803 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.431 | 0.453 | 0.561 | 0.644 | 0.746 |
Dividends per Share |